Group 1 - Renuvion has been recognized as the 1 trusted body contouring technology by plastic and cosmetic surgeons in an independent survey conducted by Wakefield Research, highlighting its effectiveness in targeting loose skin [1][3] - The technology is the first and only FDA-cleared device for contracting subcutaneous tissue and is preferred by 4 out of 5 surgeons for use after liposuction, which was the most common cosmetic surgical procedure in 2023 with nearly 2.3 million performed [3] - Apyx Medical has secured four FDA 510(k) clearances in the past two years, demonstrating its commitment to evidence-based outcomes through advanced technology [2] Group 2 - Renuvion has treated over 350,000 patients since its market launch, aiming to improve physical, mental, and emotional well-being [2] - The company emphasizes the importance of trust and results in the plastic surgery industry, supported by over 90 clinical papers and peer-reviewed studies [2] - Apyx Medical Corporation specializes in advanced energy technology, with products marketed as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market, providing controlled heat to tissue for desired surgical outcomes [4]
Renuvion Named #1 Trusted Body Contouring Technology by Doctors*